Edition:
United States

Hunan Er-Kang Pharmaceutical Co Ltd (300267.SZ)

300267.SZ on Shenzhen Stock Exchange

5.09CNY
14 Feb 2018
Change (% chg)

¥-0.05 (-0.97%)
Prev Close
¥5.14
Open
¥5.14
Day's High
¥5.18
Day's Low
¥5.07
Volume
9,376,428
Avg. Vol
31,193,648
52-wk High
¥14.22
52-wk Low
¥4.81

Latest Key Developments (Source: Significant Developments)

Hunan Er-Kang Pharmaceutical says freeze of shares
Monday, 5 Feb 2018 08:53pm EST 

Feb 6 (Reuters) - Hunan Er-Kang Pharmaceutical Co Ltd <300267.SZ>:Says 74 million shares (3.6 percent stake) held by Hunan-based investment firm were frozen from Jan. 31, 2018 to Jan. 30, 2019 .  Full Article

Hunan Er-Kang Pharmaceutical says freeze of top shareholder's shares
Thursday, 1 Feb 2018 05:04am EST 

Feb 1 (Reuters) - Hunan Er-Kang Pharmaceutical Co Ltd <300267.SZ>:Says 157.9 million shares (7.7 percent stake) held by top shareholder were frozen by Hunan High People's Court, from Jan. 25, 2018 to Jan. 24, 2019 .  Full Article

Hunan Er-Kang Pharmaceutical says dissolution of Hunan-based unit
Wednesday, 10 Jan 2018 10:50pm EST 

Jan 11(Reuters) - Hunan Er-Kang Pharmaceutical Co Ltd <300267.SZ>:Says it completed dissolution of wholly owned Hunan-based pharmaceutical unit .  Full Article

Hunan Er-Kang Pharmaceutical receives three Canadian patents
Sunday, 3 Dec 2017 10:40pm EST 

Dec 4 (Reuters) - Hunan Er-Kang Pharmaceutical Co Ltd <300267.SZ>:Says it received three patents for manufacturing method of starch-based soft capsule and preparation process of starch self-reinforced composite material for capsule articles, from Canadian Intellectual Property Office.  Full Article

Hunan Er-Kang Pharmaceutical's Q3, 9-month net profits down
Friday, 27 Oct 2017 05:56am EDT 

Oct 27 (Reuters) - Hunan Er-Kang Pharmaceutical Co Ltd <300267.SZ>:Says its 9-month net profit down 23.2 percent y/y at 554.8 million yuan ($83.47 million).Says its Q3 net profit down 32.4 percent y/y.  Full Article

Hunan Er-kang Pharmaceutical receives patent license from Canadian Intellectual Property Office
Thursday, 26 Oct 2017 10:18pm EDT 

Oct 27 (Reuters) - Hunan Er-kang Pharmaceutical Co Ltd <300267.SZ>:Says it received a patent license (No. 2872353), for the manufacturing method of membrane compound of soft capsule, from Canadian Intellectual Property Office .  Full Article

Hunan Er-kang Pharmaceutical sees Q3, 9-month net profits down
Friday, 13 Oct 2017 08:12am EDT 

Oct 13 (Reuters) - Hunan Er-kang Pharmaceutical Co Ltd <300267.SZ>:Says it sees 9-month net profit down 15-28 percent from 722.6 million yuan ($109.70 million).Says it sees Q3 net profit down 2-50 percent y/y.  Full Article

Hunan Er-kang Pharmaceutical says change of accounting policy
Tuesday, 29 Aug 2017 11:46pm EDT 

Aug 30(Reuters) - Hunan Er-kang Pharmaceutical Co Ltd <300267.SZ> ::* Says it changed the accounting policy due to national policy requirement.  Full Article

Hunan Er-Kang Pharmaceutical's H1 net profit down 19.8 pct y/y
Tuesday, 29 Aug 2017 07:55am EDT 

Aug 29 (Reuters) - Hunan Er-Kang Pharmaceutical Co Ltd <300267.SZ>:Says H1 net profit down 19.8 percent y/y at 422.7 million yuan ($64.11 million).  Full Article

Hunan Er-Kang Pharmaceutical sees H1 net profit flat to down, probed by regulator
Wednesday, 9 Aug 2017 06:27am EDT 

Aug 9 (Reuters) - Hunan Er-Kang Pharmaceutical Co Ltd <300267.SZ>:Says it is investigated by securities regulator for possible violations of information disclosure.Says it sees H1 net profit flat to down 25 percent y/y at 395.3-527.1 million yuan ($59.20-78.94 million).  Full Article